Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:CB

Chubb Limited (CB)

326.95
-1.19 (0.36%)
as of Jun 15, 2026, 8:00:00 pm Market Open.
51 watching
0
Investor Insights
star iconJun 15, 2026, 12:00 am

This summary was created by AI, based on 8 opinions in the last 12 months.

Chubb Limited (CB-N) continues to garner positive evaluations from various experts, suggesting its strong positioning in the insurance sector despite recent challenges in pricing pressures. The company maintains a low combined ratio of 86%, indicating effective underwriting practices that generate significant revenues. Several analysts highlight its defensive nature and robust portfolio of investment-grade bonds, making it an attractive anchor in a diversified portfolio. However, there are cautionary notes regarding the impact of rising catastrophic events and a shifting interest rate environment that may affect the sector. While some experts are optimistic about its future potential and recommend buying at current levels, others suggest a more cautious approach, advising investors to wait for price confirmation before increasing positions.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
Allianz,ALV
TOP PICK

It is the largest property and casualty insurance provider in the world and has a very good management team. It pays out less than 90% in claims and expenses. Trades at 10X earnings and 1 1/2 P/B with a yield of 3 1/2%.  It has U.S. and international exposure and has the money to invest in new fixed income and other products.    Buy 16  Hold 7  Sell 1

TOP PICK

Global, with 40% of premiums coming from outside US. Deep product offerings. Grows through acquisition as well. Valuation has pulled back to an attractive 10x forward earnings. Very disciplined underwriting. Rising rates are a tailwind for its investments in fixed income. Well-respected management. Yield is 1.81%.

(Analysts’ price target is $235.16)
BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

CB pays a good yield of 1.8%, has grown its sales and earnings decently over the past five years, with a five-year sales and earnings CAGR of 6.2% and 6.4%, respectively. Analysts estimate good growth in the future years, with earnings estimates of 19% and sales estimates of 7.5% for this year. Most insurance companies generate a significant amount of earnings from their investment portfolios, which are mostly made up of bonds, and so high interest rate environments can help their bottom line, however, decline in rates will also help bond prices. Management has done an excellent job and Evan Greenberg, the CEO has over 45 years of insurance experience and joined the company over 20 years ago. We think the name is buyable here.
Unlock Premium - Try 5i Free

PAST TOP PICK
(A Top Pick Jun 08/22, Down 8%)

Continues to hold stock.
Excellent fundamentals.
Good for long term investors who want a predictable business.
Underwriting & bond portfolio performing well. 

TOP PICK

Very respected insurance company.
Massive asset book with diversified business model.
Combined ratio in 85% range (very good). Equated to ~15% margin. 
Bond holdings also performing well.
Not concerned about rise of AI.

TOP PICK

Just bought it. Is a global P&C insurer. Well-run. Are good underwriters. Their combined ratio is below 90%. They grow acquiring, most recently life expanding into insurance in Asia. Pays only a modest dividend, but offers strong growth.

(Analysts’ price target is $242.36)
TOP PICK

Just added on pullback. Strong managers which is key for PC insurers. Are excellent underwriters in assessing risk. Their combined ratio has been 90% or less. Also, they have a global presence, with 60% in North America and 40% outside.  Have many commercial and personal lines and have just expanded in accidental and life insurance in Asia. Diverse and deep. Investment portfolio is conservative, about 87% in investment-grade bonds. Shares down 20% on the current pullback. PE is 10.5x forward is attractive. Pays only 1.7% yield, but good company growth ahead.

(Analysts’ price target is $244.55)
PARTIAL BUY

A quality insurer and leads the industry in margins. It's pulled back enough this year that you can add a little now, but there are other defensive names like JNJ to consider too.

HOLD

Come off the last few months, primarily because of investments in bonds. Over the long term, rolling over bonds in a higher rate environment is a benefit. Solid holding. Pricing power on insurance side. Very well managed. 1.3x book, a good fair price.

TOP PICK
Insurance companies have more pricing power than banks right now. 15% price increases when they're offlaying a lot of their risk. One of the biggest, high credit rating. Combined ratio is the lowest in the industry. Investment portfolio is 100% fixed income, so it benefits from increasing rates. Yield is 1.5%. (Analysts’ price target is $237.58)
PAST TOP PICK
(A Top Pick Oct 19/21, Up 6%) Hung in quite well in a challenging environment. P&C has pricing power again, plus doing well on investments. Hurricanes don't hurt it that much, as it moves a lot of the liability off the balance sheet to reinsurers. These big events give them pricing power. AAA reputation, the best of the best.
TOP PICK
Strong pricing trends in the industry. Covering all costs through underwriting alone, and all other income is gravy. Investments benefit from rising rates. 1.3x book. Growing well organically, has legs. Yield is 1.57%. (Analysts’ price target is $231.05)
PAST TOP PICK
(A Top Pick Apr 13/21, Up 34.12%) Adding for new clients. Pricing power has returned to insurers. Organic growth. Bond portfolios are worth more with rising rates. Should earn $14.50 or so EPS in 2022. Prospects for double-digit growth in 2023 are there. Relatively inexpensive, growing well.
TOP PICK
Believes it is a great time to be in the insurance industry. Every 1% rise in interest rates = additional $1.2 billion income for the company. Expectation is for price increases (10%) at all insurance companies. Very good credit rating.
WEAK BUY
Generally likes insurers. Benefits from a rise in interest rates. Scores okay on price momentum. Not too expensive at 16x. Small yield, good balance sheet. Not a stand out, prefers Manulife.
Showing 31 to 45 of 68 entries